A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2015

A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment

Fichier principal
Vignette du fichier
Samalinetal.-2015-P-161AphaseI-trialassessingseveralschedule.pdf (31.31 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02310075 , version 1 (09-10-2019)

Identifiants

Citer

E. Samalin, S. Thezenas, J.-P Delord, A. Italiano, D. Smith, et al.. A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment. ESMO 17th World Congress on Gastrointestinal Cancer, Jul 2015, barcelona, Spain. pp.iv47-iv47, ⟨10.1093/annonc/mdv233.161⟩. ⟨hal-02310075⟩
33 Consultations
52 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More